文献速递功能神经外科

SEEG引导下切除性手术后癫痫发作结局的决定因素

Determinants of seizure outcome after resective surgery following stereoelectroencephalography.
PubMed 文献 · J Neurosurg · 2021-10-22

该单中心回顾性研究分析了536例接受SEEG评估的药物难治性癫痫患者,其中341例后续行切除性手术。术后1年、3年、5年持续无发作率分别为55.5%、44%、39%,末次随访时58%患者达到Engel I级;多因素分析显示切除类型、既往切除史和双侧植入是复发预测因素,MRI阴性不影响结局。

要点

  • SEEG引导切除术后5年持续无发作率约39%,末次随访Engel I级达58%。
  • 额叶和颞叶切除复发风险最低,多脑叶和 posterior quadrant 切除风险较高。
  • 既往切除史和双侧SEEG植入与复发风险增加相关,MRI阴性不显著影响结局。

核心结论

  • SEEG评估后切除性手术可使复杂药物难治性癫痫患者获得持续无发作,末次随访高达58%达到Engel I级。

研究设计与样本

  • 回顾性单中心队列研究,纳入2009至2017年Cleveland Clinic癫痫中心536例连续接受SEEG评估的患者,其中527例符合标准,341例接受切除性手术。

主要发现

  • 术后1年、3年、5年持续无发作率分别为55.5%、44%、39%。
  • 末次随访时58%患者达到Engel I级至少1年。
  • 多因素分析中切除类型(p=0.039)与复发显著相关,额叶和颞叶切除复发风险最低。
  • 既往切除史(p=0.006)和双侧植入(p=0.023)与复发风险增加相关。
  • 切除前MRI无异常在本队列中未显著影响癫痫结局。

关键数值与推荐

  • 持续无发作定义为切除术后完全无发作,忽略术后第1周内的先兆或发作。
  • Engel I级结局基于随访≥1年的患者评估。

临床怎么用

  • SEEG评估后行切除性手术可为复杂药物难治性癫痫提供持续无发作机会,额叶和颞叶切除预后较好。
  • 对有既往切除史或需双侧SEEG植入的患者应预期更高复发风险,MRI阴性患者仍可考虑手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to investigate seizure outcomes after resective epilepsy surgery following stereoelectroencephalography (SEEG), including group characteristics, comparing surgical and nonsurgical groups and assess predictors of time to seizure recurrence. METHODS: Clinical and EEG data of 536 consecutive patients who underwent SEEG at Cleveland Clinic Epilepsy Center between 2009 and 2017 were reviewed. The primary outcome was defined as complete seizure freedom since the resective surgery, discounting any auras or seizures that occurred within the 1st postoperative week. In addition, the rate of seizure freedom based on Engel classification was determined in patients with follow-up of ≥ 1 year. Presumably significant outcome variables were first identified using univariate analysis, and Cox proportional hazards modeling was used to identify outcome predictors. RESULTS: Of 527 patients satisfying study criteria, 341 underwent resective surgery. Complete and continuous seizure freedom after surgery was achieved in 55.5% of patients at 1 year postoperatively, 44% of patients at 3 years, and 39% of patients at 5 years. As a secondary outcome point, 58% of patients achieved Engel class I seizure outcome for at least 1 year at last follow-up. Among surgical outcome predictors, in multivariate model analysis, the seizure recurrence rate by type of resection (p = 0.039) remained statistically significant, with the lowest risk of recurrence occurring after frontal and temporal lobe resections compared with multilobar and posterior quadrant surgeries. Patients with a history of previous resection (p = 0.006) and bilateral implantations (p = 0.023) were more likely to have seizure recurrence. The absence of an MRI abnormality prior to resective surgery did not significantly affect seizure outcome in this cohort. CONCLUSIONS: This large, single-center series shows that resective surgery leads to continuous seizure freedom in a group of patients with complex and severe pharmacoresistant epilepsy after SEEG evaluation. In addition, up to 58% of patients achieved seizure freedom at last follow-up. The authors' results suggest that SEEG is equally effective in patients with frontal and temporal lobe epilepsy with or without MRI identified lesions.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Bulacio JC, Bena J, Suwanpakdee P, et al. Determinants of seizure outcome after resective surgery following stereoelectroencephalography. J Neurosurg. 2021. PMID: 34678771. doi:10.3171/2021.6.JNS204413

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。